Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
69 participants
INTERVENTIONAL
2023-10-28
2024-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systane® Complete Preservative Free Lubricant Eye Drops
NCT05932225
Systane® Hydration PF and Systane® Hydration Preserved
NCT05932238
The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance
NCT00673764
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
NCT01863368
Evaluation of SYSTANE Ultra Lubricant Eye Drops
NCT00702377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 - Dry Eye Symptoms
1-2 drops of Systane Ultra PF lubricant eye drops in each eye four times a day for 30 days
Systane Ultra PF lubricant eye drops
Commercially available preservative free eye drops
Group 2 - CL-Related Dryness Discomfort
1-2 drops of Systane Ultra PF lubricant eye drops in each eye four times a day for 30 days
Systane Ultra PF lubricant eye drops
Commercially available preservative free eye drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Systane Ultra PF lubricant eye drops
Commercially available preservative free eye drops
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject with mild to moderate dry eye.
* Subject with contact lens-related dry eye symptoms.
Exclusion Criteria
* Has undergone any other ocular surgery (including intraocular surgery) within the past 6 months or has any ocular surgery planned during the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Integra Eye Care
Burnaby, British Columbia, Canada
University of Waterloo School of Optometry
Waterloo, Ontario, Canada
University of Auckland
Grafton, Auckland, New Zealand
Rose Optometry
Frankton, Otago, New Zealand
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEU894-I001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.